Florence Rozen

Lumira Capital Investment Management is a Venture Capital firm, a subsidiary of Nordion (Canada),Inc. founded in 1989 by Tony Pullen. The firm is headquartered in Toronto.

Viron Therapeutics, Inc. discovers and develops novel therapeutics for inflammatory disorders. Its products include VT-111a, a recombinant protein that functions to reduce monocyte infiltration to sites of viral infection, as well as inhibits cardiovascular damage due to coronary stent placement. The firm also develops VT-310, a glycoprotein for the treatment of cancer, VT-384 that inhibit interferon gamma production, VT-346, a glycoprotein that protects against human TNF-mediated inflammatory signals and VT-214, a chemokine binding protein. The company was founded in 1997 and is headquartered in London, Canada.

Ontario Genomics Institute (Private Equity) is a Venture Capital firm in UK. The firm was founded in 2001. The firm is headquartered in London.

Robarts Research Institute engages in the provision of medical research facilities for investigating various diseases such as diabetes, heart and stroke, Alzheimer's, and cancer diseases. The company was founded by Henry Barnett in 1986 and is headquartered in London, Canada.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Twinstrand Therapeutics Inc. manufactures and distributes biological drugs. It focuses on discovering, developing and commercializing of therapeutics for the treatment of cancer, hepatitis A, cytomegalovirus, malaria, schistosomiasis, and fungal diseases. The company was founded in 1995 and is located in North Vancouver, Canada.

CellAegis Devices, Inc. develops device for the treatment of cardiac patients. . It offers autoRIC Device, an automated noninvasive device that provides point of care delivery of remote ischemic conditioning. The company was founded by John Berton, Andrew N. Redington and Christopher Caldarone and is headquartered in Toronto, Canada.

Crimson Capital, Inc. provides investment services. The joint venture company is based in Albany, NY. The company was founded by Roland Eschle. Linda Boland Abraham has been the CEO of the company since 2014.

ViOptix, Inc. develops a tissue oximetry technology for the measurement of local tissue oxygen saturation. It offers T.Ox Tissue Oximeter, a lightweight and portable A/C power-operated unit. The was founded in 2009 and is headquartered in Fremont, CA.

Part of Topicus.com, Inc., Topicus.com BV provides vertical market software and platforms. The company is based in Deventer, Netherlands. Robin van Poelje has been the CEO of the Dutch company since 2021.

Cross-Border Impact Ventures (Cross-Border Impact Ventures) is a venture capital firm founded in 2019 by Megan Dover. The firm is headquartered in Toronto, Canada.

EndoCeutics, Inc. develops hormone therapies. It offers products for vulvovaginal atrophy-sexual dysfunction, treatment of hot flushes and loss of bone, breast cancer treatment, treatment of endometriosis, treatment of prostate cancer, and male hypogonadism. The company was founded on July 26, 2006 and is headquartered in Quebec, Canada.

MedInnova Partners, Inc is a venture capital firm, founded in 2000. The firm headquartered in Halifax, Nova Scotia.

NATRIX Separations, Inc. manufactures and supplies single use and multi-cycle disposable chromatography products to the life science, food, beverage and water markets. Its technology consists of a polymeric hydrogel formed within a flexible porous support matrix. The firm offers NatriFlo HD-Q membrane absorbers for single-use flow-through polish applications and Natrix HD-C hydrogel membrane devices for bind-elute applications. The company was founded by Alicja Mika, Lisa Crossley, and Ronald F. Childs in 2004 and is headquartered in Burlington, Canada.

ID Biomedical Corp. develops gene-based disease testing and subunit vaccines. It conducts research, development, manufacturing, sales, and marketing from its facilities in Canada and in the United States. The company was founded in 1991 and is headquartered in Vancouver, Canada.

Ellipsis Neurotherapeutics, Inc. develops pharmaceutical products for treatment and preventing of Alzheimer's disease and related disorders. The firm commercializes neurodegenerative disease therapeutics and diagnostics. The company was founded by Laurence Rubin in November 2004 and is headquartered in Toronto, Canada.

PainCeptor Pharma Corp. operates as a biopharmaceutical company which engages in the development of pharmaceuticals for chronic and acute pain. It offers next generation therapeutic drugs for the treatment of chronic and acute pain. The firms products includes NGF/p75-TrkA, ASIC1a and ASIC3. The company was founded by Louis Lamontagne in 2003 and is headquartered in St-Laurent, Canada.

Ception Therapeutics, Inc. Develops pharmaceutical products. It focuses on the discovery and development of novel products to address areas of unmet medical need. The company was founded in 2004 and is headquartered in Malvern, PA.

DC Bio Corp. develops technology for application to cancer and diseases associated with chronic viral infections. The company is headquartered in Halifax, Canada.

OsteoqQC, Inc. develops drugs for the treatment of bone-related diseases. The company was founded by Debra Ellies and is headquartered in Montreal, Canada.

Mcmaster Innovation Park operates as a premier research park that offers collaborative space for researchers and entrepreneurs to co-locate, connect and commercialize. The company is headquartered in Hamilton, Canada.